Product Information
LAMOTRIGINE ODT 25 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.2668 per EA under NDC 49884048411. Its NADAC has been published 523 times since May 18, 2016.
FDA first approved this application on Oct 27, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Endo USA Inc.NDC
49884048411
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA204158FDA Approved
10/27/2015
TE Code
AB
On Market Since
12/16/2015
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ODT 25 MG TABLET has been published 523 times since May 18, 2016, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2668 per EA |
|---|---|
| All-time high | $6.2049 (Jul 13, 2016) |
| All-time low | $1.0506 (May 20, 2026) |
| 52-week high | $1.8894 |
| 52-week low | $1.0506 |
| Median price | $4.2213 |
| Average price | $3.8070 |
| Largest weekly change | +75.0% (Jan 17, 2024) |
| Weeks tracked | 523 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ODT 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 25 MG TABLET, manufactured by Endo USA Inc., is $1.2668 per EA (NDC 49884048411), effective Aug 19, 2026.
How has the price of LAMOTRIGINE ODT 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ODT 25 MG TABLET has declined 79.6%. It has been tracked across 523 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 25 MG TABLET?
Since May 18, 2016, the NADAC for LAMOTRIGINE ODT 25 MG TABLET has ranged from a low of $1.0506 (May 20, 2026) to a high of $6.2049 (Jul 13, 2016), with a median of $4.2213 per EA.
Are there cheaper alternatives to LAMOTRIGINE ODT 25 MG TABLET?
Yes. 19 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG TABLET, is $0.0271 per EA — about 98% below LAMOTRIGINE ODT 25 MG TABLET.
Who manufactures LAMOTRIGINE ODT 25 MG TABLET?
LAMOTRIGINE ODT 25 MG TABLET (NDC 49884048411) is labeled by Endo USA Inc., and CMS classifies it as a generic product.